SEC Form 4 · accession 0001654954-19-001562
AYTU BIOPHARMA, INC · AYTU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ketan Bhupatrai Mehta
Officer — Chief Financial Officer
Period of report
Feb 13, 2019
Accepted (ET)
Feb 14, 2019 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2019 | A | 65,000 | — | A | 65,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These are restricted shares which vest on February 13, 2029, subject to earlier vesting in certain situations.